<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00977639</url>
  </required_header>
  <id_info>
    <org_study_id>SU-03072008-1032</org_study_id>
    <secondary_id>98301</secondary_id>
    <secondary_id>VAR0029</secondary_id>
    <nct_id>NCT00977639</nct_id>
  </id_info>
  <brief_title>Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies</brief_title>
  <official_title>Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      The pathworks tissue of origin test is a microarray-based test with the goal of identifying
      the tissue of origin in patients with metastatic tumors of unknown primary site.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">2</enrollment>
  <condition>Neoplasm Metastasis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pathwork TOO test</intervention_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      a tissue biopsy specimen
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of malignancy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:1 Subjects must be at least 18 years old. The TOO test is designed to
        determine the tissue of origin of common adult malignancies. There are no gender/ethnic
        restrictions.

        2 Patients with a diagnosis of malignancy established by pathologic review of H&amp;E staining
        of tumor biopsy or tumor resection without definitive determination of tissue of origin as
        assessed by the PI. Samples must have been obtained within three months of enrollment, or
        the patient must still be under active evaluation for tissue of origin at the time of
        enrollment. There are no limitations on prior therapy and time from last prior therapy.

        3 Ability to understand and the willingness to sign a written informed consent document.

        Exclusion Criteria:1 Patients under the age of 18 are excluded. There are no exclusions
        based on gender/ethnicity.

        2 There are no exclusion requirements due to co-morbid disease or incurrent illness, as
        needed.

        3 Pregnancy or nursing participants will not be excluded from the study.

        4 Patients with a diagnosis of leukemia including acute myelogenous leukemia, acute
        lymphocytic leukemia, hairy cell leukemia, chronic myelogenous leukemia and chronic
        lymphocytic leukemia are excluded from enrollment on this study. The TOO test does not
        cover these diagnoses.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James L Zehnder</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2009</study_first_submitted>
  <study_first_submitted_qc>September 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2009</study_first_posted>
  <last_update_submitted>March 26, 2010</last_update_submitted>
  <last_update_submitted_qc>March 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>James L Zehnder</name_title>
    <organization>Stanford University School of Medicine</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

